EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Extracellular Vesicles as Delivery Vehicles for Non-Coding RNAs: Potential Biomarkers for Chronic Liver Diseases

Arianna Ferro, Gabriele Saccu, Simone Mattivi iD, Andrea Gaido, Maria Beatriz Herrera Sanchez iD, Shafiul Haque iD, Lorenzo Silengo, Fiorella Altruda iD, Marilena Durazzo iD, Sharmila Fagoonee iD

Biomolecules · 26.02.2024 · 14 (3) · 277

DOI: 10.3390/biom14030277 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 26.02.2024. Verfasst von Arianna Ferro und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Sciences, University of Turin, 10126 Turin, Italy. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Carcinoma, Hepatocellular, Liver Neoplasms, MicroRNAs. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 168 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia, Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In recent years, EVs have emerged as promising vehicles for coding and non-coding RNAs (ncRNAs), which have demonstrated remarkable potential as biomarkers for various diseases, including chronic liver diseases (CLDs). EVs are small, membrane-bound particles released by cells, carrying an arsenal of ncRNAs, including microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and other ncRNA species, such as piRNAs, circRNAs, and tsRNAs. These ncRNAs act as key regulators of gene expression, splicing, and translation, providing a comprehensive molecular snapshot of the cells of origin. The non-invasive nature of EV sampling, typically via blood or serum collection, makes them highly attractive candidates for clinical biomarker applications. Moreover, EV-encapsulated ncRNAs offer unique advantages over traditional cell-free ncRNAs due to their enhanced stability within the EVs, hence allowing for their detection in circulation for extended periods and enabling more sensitive and reliable biomarker measurements. Numerous studies have investigated the potential of EV-enclosed ncRNAs as biomarkers for CLD. MiRNAs, in particular, have gained significant attention due to their ability to rapidly respond to changes in cellular stress and inflammation, hallmarks of CLD pathogenesis. Elevated levels of specific miRNAs have been consistently associated with various CLD subtypes, including metabolic dysfunction-associated steatotic liver disease (MASLD), metabolic dysfunction-associated steatohepatitis (MASH), and chronic hepatitis B and C. LncRNAs have also emerged as promising biomarkers for CLD. These transcripts are involved in a wide range of cellular processes, including liver regeneration, fibrosis, and cancer progression. Studies have shown that lncRNA expression profiles can distinguish between different CLD subtypes, providing valuable insights into disease progression and therapeutic response. Promising EV-enclosed ncRNA biomarkers for CLD included miR-122 (elevated levels of miR-122 are associated with MASLD progression and liver fibrosis), miR-21 (increased expression of miR-21 is linked to liver inflammation and fibrosis in CLD patients), miR-192 (elevated levels of miR-192 are associated with more advanced stages of CLD, including cirrhosis and HCC), LncRNA HOTAIR (increased HOTAIR expression is associated with MASLD progression and MASH development), and LncRNA H19 (dysregulation of H19 expression is linked to liver fibrosis and HCC progression). In the present review, we focus on the EV-enclosed ncRNAs as promising tools for the diagnosis and monitoring of CLD of various etiologies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Long NoncodingCarcinoma, HepatocellularLiver NeoplasmsMicroRNAsExtracellular VesiclesFatty LiverHumansRNA, UntranslatedBiomarkersLiver Cirrhosis

Stichwörter der Autor:innen

biomarkerschronic liver diseasesdiagnosisextracellular vesiclesnon-coding RNAs

Substanzen

RNA, Long NoncodingRNA, UntranslatedMicroRNAsBiomarkers

Autor:innen und Institutionen

  • Department of Medical Sciences, University of Turin, 10126 Turin, Italy.
  • 2i3T, Società per la Gestione Dell'incubatore di Imprese e per il Trasferimento Tecnologico, University of Torino, 10126 Turin, Italy.
  • Molecular Biotechnology Centre "Guido Tarone", 10126 Turin, Italy.
  • Research and Scientific Studies Unit, College of Nursing and Health Sciences, Jazan University, Jazan 45142, Saudi Arabia.
  • Centre of Medical and Bio-Allied Health Sciences Research, Ajman University, Ajman 13306, United Arab Emirates.
  • Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Beirut 1102 2801, Lebanon.

ORCID-Profile: Simone Mattivi, Maria Beatriz Herrera Sanchez, Shafiul Haque, Fiorella Altruda, Marilena Durazzo, Sharmila Fagoonee

Förderung

  • Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia
  • Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia

Zitieren

APA

Ferro, A., Saccu, G., Mattivi, S., Gaido, A., Herrera Sanchez, M. B., Haque, S., Silengo, L., Altruda, F., Durazzo, M., & Fagoonee, S. (2024). Extracellular Vesicles as Delivery Vehicles for Non-Coding RNAs: Potential Biomarkers for Chronic Liver Diseases. Biomolecules, 14(3), 277. https://doi.org/10.3390/biom14030277

Vancouver

Ferro A, Saccu G, Mattivi S, Gaido A, Herrera Sanchez MB, Haque S, et al. Extracellular Vesicles as Delivery Vehicles for Non-Coding RNAs: Potential Biomarkers for Chronic Liver Diseases. Biomolecules. 2024;14(3):277. doi:10.3390/biom14030277

BibTeX
@article{Ferro2024,
  author = {Ferro, Arianna and Saccu, Gabriele and Mattivi, Simone and Gaido, Andrea and Herrera Sanchez, Maria Beatriz and Haque, Shafiul and Silengo, Lorenzo and Altruda, Fiorella and Durazzo, Marilena and Fagoonee, Sharmila},
  title = {Extracellular Vesicles as Delivery Vehicles for Non-Coding RNAs: Potential Biomarkers for Chronic Liver Diseases},
  journal = {Biomolecules},
  year = {2024},
  volume = {14},
  number = {3},
  pages = {277},
  doi = {10.3390/biom14030277}
}
Kostenlos starten →